Estrogen receptor activation remodels TEAD1 gene expression to alleviate nonalcoholic fatty liver disease
Christian Sommerauer, Carlos J. Gallardo-Dodd, Christina Savva, Linnea Hases, Madeleine Birgersson, Rajitha Indukuri, Joanne X. Shen, Pablo Carravilla, Keyi Geng, Jonas Nørskov Søndergaard, Clàudia Ferrer-Aumatell, Grégoire Mercier, Erdinç Sezgin, Marion Korach-André, Carl Petersson, , Claudia Kutter
This study shows that activating estrogen receptors in male mice reduces HFD-induced liver steatosis by modulating gene expression and TEAD1, suggesting TEAD1 inhibition as a therapeutic strategy for NAFLD.
Molecular Systems Biology · Mar 8, 2024Peer-reviewedGenomics